Transitional Drugs 7
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · All their open notices
What this is
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) has issued a UK4 tender (contract) notice for Transitional Drugs 7. The provision of Drugs which have lost or are shortly to lose exclusivity, namely Eculizumab; Icatibant; Nintedanib; Omalizumab; Tocilizumab Estimated value approximately GBP 53,566,932. Submission deadline 2026-05-29.
Key points
- Notice type: UK4 (live tender).
- Main CPV 33600000 - Pharmaceutical products.
- Estimated value GBP 53,566,932.
- Deadline 2026-05-29.
- Award: 1% quality.
- Delivery: Wales.
Who can bid
As per the tender documents. Conditions
How it is scored
Award based on 1% quality.
How to submit
Submit via the e-procurement portal; see notice for details: https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=APR606793.
Clarifications
Clarification questions to be raised via the e-procurement portal by the deadline stated in the tender documents.
Contract period
Start: 01 July 2026, 00:00AM. End: 30 June 2028, 23:59PM. Approx. 23 months. Extension option available.
Classification
CPV 33600000 — Pharmaceutical products Wales
Published on Sell2Wales. The official notice is the authoritative version.